Ocuphire Pharma Net Income 2010-2024 | IRD
Ocuphire Pharma net income from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Ocuphire Pharma Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-10 |
| 2022 | $18 |
| 2021 | $-57 |
| 2020 | $-25 |
| 2019 | $-6 |
| 2018 | $-14 |
| 2017 | $-25 |
| 2016 | $-9 |
| 2015 | $-14 |
| 2014 | $-19 |
| 2013 | $-9 |
| 2012 | $-6 |
| 2011 | $-11 |
| 2010 | $-14 |
| 2009 | $-3 |
| Ocuphire Pharma Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-8 |
| 2024-03-31 | $-7 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $6 |
| 2023-06-30 | $-5 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $34 |
| 2022-09-30 | $-5 |
| 2022-06-30 | $-5 |
| 2022-03-31 | $-7 |
| 2021-12-31 | $-6 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-39 |
| 2020-12-31 | $-19 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-3 |
| 2019-12-31 | $1 |
| 2019-09-30 | $-2 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-2 |
| 2018-12-31 | $-3 |
| 2018-09-30 | $-5 |
| 2018-06-30 | $-4 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-4 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $-22 |
| 2016-12-31 | $-1 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-4 |
| 2015-12-31 | $-3 |
| 2015-09-30 | $-4 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-2 |
| 2014-06-30 | $0 |
| 2014-03-31 | $-15 |
| 2013-12-31 | $-3 |
| 2013-09-30 | $-2 |
| 2013-06-30 | $-3 |
| 2013-03-31 | $-2 |
| 2012-12-31 | $-0 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-2 |
| 2011-12-31 | $0 |
| 2011-09-30 | $-1 |
| 2011-06-30 | $-6 |
| 2011-03-31 | $-4 |
| 2010-12-31 | $-3 |
| 2010-09-30 | $0 |
| 2010-06-30 | $-4 |
| 2010-03-31 | $-8 |
| 2009-12-31 | $2 |
| 2009-09-30 | $-1 |
| 2009-06-30 | $-2 |
| 2009-03-31 | $-1 |
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fanhua (AIFU) | China | $0.086B | 2.07 |
| Top KingWin (WAI) | China | $0.008B | 0.00 |
| S&W Seed (SANW) | United States | $0.006B | 0.00 |
| Invo BioScience (NAYA) | United States | $0.004B | 0.00 |